Systems metabolic engineering, industrial biotechnology and microbial cell factories

Microbial Cell Factories

Volumn 11, Issue , 2012, Pages

  Lee, Sang Yup ^a   Mattanovich, Diethard ^b,c   Villaverde, Antonio ^d,e  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

^c AUSTRIAN CENTRE OF INDUSTRIAL BIOTECHNOLOGY   (Austria)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

BIOTECHNOLOGY; COMPUTER MODEL; EDITORIAL; GENE REGULATORY NETWORK; METABOLIC ENGINEERING; METABOLIC REGULATION; MICROBIAL ACTIVITY; NONHUMAN; SYSTEM METABOLIC ENGINEERING;

BIOTECHNOLOGY; ESCHERICHIA COLI; METABOLIC ENGINEERING; SACCHAROMYCES CEREVISIAE;

EID: 84870704590     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-11-156     Document Type: Editorial

References (43)

1. ANONIMOUS Human insulin receives FDA approval. FDA Drug Bull 1982, 12:18-19. ANONIMOUS.
2. Johnson IS. Human insulin from recombinant DNA technology. Science 1983, 219:632-637. 10.1126/science.6337396, 6337396.
3. Marston FA. The purification of eukaryotic polypeptides synthesized in escherichia coli. Biochem J 1986, 240:1-12. 1147368, 3548705.
4. Makino T, Skretas G, Georgiou G. Strain engineering for improved expression of recombinant proteins in bacteria. Microb Cell Fact 2011, 10:32. 10.1186/1475-2859-10-32, 3120638, 21569582.
5. Lee SY, Lee DY, Kim TY. Systems biotechnology for strain improvement. Trends Biotechnol 2005, 23:349-358. 10.1016/j.tibtech.2005.05.003, 15923052.
6. Park JH, Lee SY, Kim TY, Kim HU. Application of systems biology for bioprocess development. Trends Biotechnol 2008, 26:404-412. 10.1016/j.tibtech.2008.05.001, 18582974.
7. Lee SY, Kim HU, Park JH, Park JM, Kim TY. Metabolic engineering of microorganisms: general strategies and drug production. Drug Discov Today 2009, 14:78-88. 10.1016/j.drudis.2008.08.004, 18775509.
8. Na D, Kim TY, Lee SY. Construction and optimization of synthetic pathways in metabolic engineering. Curr Opin Microbiol 2010, 13:363-370. 10.1016/j.mib.2010.02.004, 20219419.
9. Lee JW, Kim TY, Jang YS, Choi S, Lee SY. Systems metabolic engineering for chemicals and materials. Trends Biotechnol 2011, 29:370-378. 10.1016/j.tibtech.2011.04.001, 21561673.
10. Adrio JL, Demain AL. Genetic improvement of processes yielding microbial products. FEMS Microbiol Rev 2006, 30:187-214. 10.1111/j.1574-6976.2005.00009.x, 16472304.
11. Demain AL, Adrio JL. Strain improvement for production of pharmaceuticals and other microbial metabolites by fermentation. Prog Drug Res 2008, 65:251. 253-251, 289, 10.1007/978-3-7643-8117-2_7, 18084918.
12. Adrio JL, Demain AL. Recombinant organisms for production of industrial products. Bioeng Bugs 2010, 1:116-131. 10.4161/bbug.1.2.10484, 3026452, 21326937.
13. Demain AL, Adrio JL. Essential role of genetics in the advancement of biotechnology. Methods Mol Biol 2012, 898:1-40. 10.1007/978-1-61779-918-1_1, 22711115.
14. Chen Z, Wilmanns M, Zeng AP. Structural synthetic biotechnology: from molecular structure to predictable design for industrial strain development. Trends Biotechnol 2010, 28:534-542. 10.1016/j.tibtech.2010.07.004, 20727604.
15. Kondo A, Ishii J, Hara KY, Hasunuma T, Matsuda F. Development of microbial cell factories for bio-refinery through synthetic bioengineering. J Biotechnol 2012, [Epub ahead of print].
16. Lee JH, Sung BH, Kim MS, Blattner FR, Yoon BH, Kim JH, et al. Metabolic engineering of a reduced-genome strain of escherichia coli for L-threonine production. Microb Cell Fact 2009, 8:2. 10.1186/1475-2859-8-2, 2634754, 19128451.
17. Ferndahl C, Bonander N, Logez C, Wagner R, Gustafsson L, Larsson C, et al. Increasing cell biomass in saccharomyces cerevisiae increases recombinant protein yield: the use of a respiratory strain as a microbial cell factory. Microb Cell Fact 2010, 9:47. 10.1186/1475-2859-9-47, 2901257, 20565740.
18. Hasunuma T, Sanda T, Yamada R, Yoshimura K, Ishii J, Kondo A. Metabolic pathway engineering based on metabolomics confers acetic and formic acid tolerance to a recombinant xylose-fermenting strain of saccharomyces cerevisiae. Microb Cell Fact 2011, 10:2. 10.1186/1475-2859-10-2, 3025834, 21219616.
19. Krainer FW, Dietzsch C, Hajek T, Herwig C, Spadiut O, Glieder A. Recombinant protein expression in pichia pastoris strains with an engineered methanol utilization pathway. Microb Cell Fact 2012, 11:22. 10.1186/1475-2859-11-22, 3295664, 22330134.
20. Ferrer-Miralles N, Domingo-Espin J, Corchero JL, Vazquez E, Villaverde A. Microbial factories for recombinant pharmaceuticals. Microb Cell Fact 2009, 8:17. 10.1186/1475-2859-8-17, 2669800, 19317892.
21. Gasser B, Saloheimo M, Rinas U, Dragosits M, Rodriguez-Carmona E, Baumann K, et al. Protein folding and conformational stress in microbial cells producing recombinant proteins: a host comparative overview. Microb Cell Fact 2008, 7:11. 10.1186/1475-2859-7-11, 2322954, 18394160.
22. Corchero JL, Gasser B, Resina D, Smith W, Parrilli E, Vazquez F, et al. Unconventional microbial systems for the cost-efficient production of high-quality protein therapeutics. Biotechnol Adv 2012, S0734(12):00151-6.
23. Gong Y, Hu H, Gao Y, Xu X, Gao H. Microalgae as platforms for production of recombinant proteins and valuable compounds: progress and prospects. J Ind Microbiol Biotechnol 2011,
24. Hempel F, Bozarth AS, Lindenkamp N, Klingl A, Zauner S, Linne U, et al. Microalgae as bioreactors for bioplastic production. Microb Cell Fact 2011, 10:81. 10.1186/1475-2859-10-81, 3214846, 22004563.
25. Meyer V, Wu B, Ram AF. Aspergillus as a multi-purpose cell factory: current status and perspectives. Biotechnol Lett 2011, 33:469-476. 10.1007/s10529-010-0473-8, 3040820, 21088867.
26. Spadiut O, Olsson L, Brumer III H. A comparative summary of expression systems for the recombinant production of galactose oxidase. Microb Cell Fact 2010, 9:68. 10.1186/1475-2859-9-68, 2949794, 20836876.
27. Le LY, Azevedo V, Oliveira SC, Freitas DA, Miyoshi A, Bermudez-Humaran LG, et al. Protein secretion in lactococcus lactis: an efficient way to increase the overall heterologous protein production. Microb Cell Fact 2005, 4:2. 10.1186/1475-2859-4-2, 545053, 15631634.
28. Morello E, Bermudez-Humaran LG, Llull D, Sole V, Miraglio N, Langella P, et al. Lactococcus lactis, an efficient cell factory for recombinant protein production and secretion. J Mol Microbiol Biotechnol 2008, 14:48-58. 10.1159/000106082, 17957110.
29. Peterbauer C, Maischberger T, Haltrich D. Food-grade gene expression in lactic acid bacteria. Biotechnol J 2011, 6:1147-1161. 10.1002/biot.201100034, 21858927.
30. Hu S, Kong J, Sun Z, Han L, Kong W, Yang P. Heterologous protein display on the cell surface of lactic acid bacteria mediated by the S-layer protein. Microb Cell Fact 2011, 10:86. 10.1186/1475-2859-10-86, 3215925, 22035337.
31. De Vos WM. Systems solutions by lactic acid bacteria: from paradigms to practice. Microb Cell Fact 2011, 10(1):S2. 10.1186/1475-2859-10-S1-S2, 3231926, 21995776.
32. Teusink B, Bachmann H, Molenaar D. Systems biology of lactic acid bacteria: a critical review. Microb Cell Fact 2011, 10(1):S11. 10.1186/1475-2859-10-S1-S11, 3231918, 21995498.
33. Rhee SJ, Lee JE, Lee CH. Importance of lactic acid bacteria in asian fermented foods. Microb Cell Fact 2011, 10(1):S5. 10.1186/1475-2859-10-S1-S5, 3231931, 21995342.
34. Siezen RJ, Van HV. Genomic diversity and versatility of lactobacillus plantarum, a natural metabolic engineer. Microb Cell Fact 2011, 10(1):S3. 10.1186/1475-2859-10-S1-S3, 3271238, 21995294.
35. Rodriguez-Carmona E, Villaverde A. Nanostructured bacterial materials for innovative medicines. Trends Microbiol 2010, 18:423-430. 10.1016/j.tim.2010.06.007, 20674365.
36. Villaverde A. Nanotechnology, bionanotechnology and microbial cell factories. Microb Cell Fact 2010, 9:53. 10.1186/1475-2859-9-53, 2916890, 20602780.
37. Vazquez E, Villaverde A. Engineering building blocks for self-assembling protein nanoparticles. Microb Cell Fact 2010, 9:101. 10.1186/1475-2859-9-101, 3022712, 21192790.
38. Lee KH, Park JH, Kim TY, Kim HU, Lee SY. Systems metabolic engineering of escherichia coli for L-threonine production. Mol Syst Biol 2007, 3:149. 2174629, 18059444.
39. Systems metabolic engineering 2012, Springer, Heidelberg, Germany, Wittmann C, Lee SY.
40. Lee JW, Na D, Park JM, Lee J, Choi S, Lee SY. Systems metabolic engineering of microorganisms for natural and non-natural chemicals. Nat Chem Biol 2012, 8:536-546. 10.1038/nchembio.970, 22596205.
41. Liu H, Xu Y, Zheng Z, Liu D. 1,3-Propanediol and its copolymers: research, development and industrialization. Biotechnol J 2010, 5:1137-1148. 10.1002/biot.201000140, 21058316.
42. Vink ETH, Glassner DA, Olstad JJWROR. The eco-profiles for current and near-future nature works polylactide (PLA) production. Ind Biotechnol 2007, 3:58-81.
43. Chen GQ. New challenges and opportunities for industrial biotechnology. Microb Cell Fact 2012, 11:111. 10.1186/1475-2859-11-111, 3520750, 22905695.